Bitcoin Acquisition

Basel Medical Group (BMGL) plans a $1B Bitcoin share-swap with crypto investors, aiming to fund Asian healthcare expansion while hedge against inflation. Critics highlight risks: crypto volatility could distort financial results, regulatory hurdles may delay execution, and shareholder dilution remains unclear. CEO Darren Chhoa stresses a hybrid strategy balancing clinical focus with “prudent” crypto exposure. Expansion targets ASEAN telemedicine and Japanese regenerative medicine markets, leveraging crypto liquidity amid elevated scrutiny. The deal blurs healthcare-investor identities, marking an outlier play on dual megatrends.